

Fundamental dimension Equity attribute | KFRCPeer $58.50▲+9.02% Cap $1.05BP/E 27.6x QuantScore45/100 | AIROPeer $4.75▼-0.63% Cap $149.9MP/E -5.7x QuantScore49/100 | BYRNLeader $4.82▼-0.41% Cap $112.8MP/E -12.7x QuantScore60/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
83/100 |
23/100 |
77/100 |
Valuation Multiples, PEG & DCF upside | 39/100 | 33/100 | 47/100 |
Health Piotroski, Altman Z, leverage & liquidity | 67/100 | 45/100 | 83/100 |
Growth Revenue / earnings growth & margins | 6/100 | 73/100 | 53/100 |
Sentiment Analyst ratings, targets & revisions | 29/100 | 70/100 | 40/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 27.6x | -5.7x | -12.7x |
Forward P/E (next FY) | 23.0x | -4.0x | -7.7x |
EV / EBITDA (TTM) | 20.4x | -32.0x | -12.8x |
Price / Sales | 0.8x | 1.4x | 1.2x |
Price / Free Cash Flow | 46.4x | -2.6x | 18.1x |
PEG ratio | -3.06 | 0.02 | 0.14 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 5 / 9 | 3 / 9 | 4 / 9 |
Altman Z-Score | 7.94 (Safe) | 2.18 (Grey) | 7.54 (Safe) |
Total debt / equity | 0.99 | 0.01 | 0.02 |
Quick ratio | 1.9x | 2.3x | 1.9x |
Interest coverage | — | -29.4x | — |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -5.4% | +4.6% | +37.7% |
Net income growth YoY | -30.9% | +89.4% | -24.3% |
Gross margin (TTM) | 27.5% | 58.7% | 54.6% |
Operating margin (FY) | 3.8% | -31.6% | 10.0% |
FCF margin (FY) | 3.5% | -39.1% | -7.8% |
5. Trailing price performancePrice change over period |
1M return | +13.9% | -34.1% | +33.1% |
3M return | +6.1% | -30.1% | +36.2% |
6M return | +80.5% | -40.1% | -21.6% |
Year to date | +89.2% | -41.9% | -71.3% |
1Y return | +110.3% | -72.8% | -77.0% |
3Y return | +3.2% | -80.2% | +15.6% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $33.69 -42.4% premium | $-19.07 -501.4% premium | $-21.94 -555.1% premium |
Wall Street consensus target | $59.00 +0.9% · range $59.00–$59.00 | $11.00 +131.6% · range $11.00–$11.00 | $4.00 -17.0% · range $3.50–$4.50 |
Consensus stance | 40% Buy60% Hold0% Sell | 67% Buy33% Hold0% Sell | 71% Buy29% Hold0% Sell |